Skip to main content

Rilmazafone

ADVERTISEMENT
Identification
Molecular formula
C26H30ClFN4O3
CAS number
99593-25-6
IUPAC name
7-chloro-5-(2-fluorophenyl)-1-[3-[4-(2-vinyloxyethyl)piperazin-1-yl]propyl]-3H-1,4-benzodiazepin-2-one
State
State

At room temperature, rilmazafone is a solid.

Melting point (Celsius)
179.00
Melting point (Kelvin)
452.20
Boiling point (Celsius)
475.40
Boiling point (Kelvin)
748.50
General information
Molecular weight
466.96g/mol
Molar mass
466.9550g/mol
Density
1.3035g/cm3
Appearence

Rilmazafone typically appears as a white crystalline powder.

Comment on solubility

Solubility of 7-chloro-5-(2-fluorophenyl)-1-[3-[4-(2-vinyloxyethyl)piperazin-1-yl]propyl]-3H-1,4-benzodiazepin-2-one

The solubility of 7-chloro-5-(2-fluorophenyl)-1-[3-[4-(2-vinyloxyethyl)piperazin-1-yl]propyl]-3H-1,4-benzodiazepin-2-one can often reflect its potential applications in pharmaceutical formulations. Understanding the solubility characteristics is crucial for both efficacy and safety. Here are some key points to consider:

  • Solvent Compatibility: This compound is likely to have varying solubility in different solvents. Polymeric or surfactant systems may enhance dissolution.
  • Influence of pH: The solubility may be pH-dependent, influenced by ionization states that can vary within different physiological environments.
  • Temperature Effects: As with many organic compounds, solubility is temperature-sensitive. Higher temperatures generally increase solubility.
  • Structure-Activity Relationship: The specific functional groups present (like the piperazine moiety) may affect hydrophilicity or lipophilicity, altering solubility.

In general, one might expect that complex organic compounds like this are designed to be soluble in organic solvents but may face challenges in aqueous environments. Understanding these solubility parameters is essential for optimizing drug formulations and enhancing bioavailability.

Interesting facts

Interesting Facts about 7-chloro-5-(2-fluorophenyl)-1-[3-[4-(2-vinyloxyethyl)piperazin-1-yl]propyl]-3H-1,4-benzodiazepin-2-one

This compound belongs to the benzodiazepine class, which is well-known for its effects on the central nervous system. As a scientist, the exploration of its pharmacological properties can unveil a myriad of applications in medicinal chemistry.

Key Characteristics:

  • Structure Complexity: The presence of multiple functional groups, including a piperazine and a vinyl ether, enhances its reactivity and potential binding affinities with various biological targets.
  • Fluorine Substitution: The introduction of a fluorine atom generally increases metabolic stability and lipophilicity, influencing the compound's pharmacokinetics.
  • Benzodiazepine Activity: Similar to other benzodiazepines, this compound may exhibit anxiolytic, sedative, or muscle relaxant properties, making it a candidate for therapeutic applications.

The intricate interplay of its components allows for a vast potential for therapeutic innovations. As quoted by many researchers, “In the world of chemistry, every atom holds a story waiting to be told.” In this case, the intricate dance between the nitrogen atoms and functional groups could unlock novel pathways for treatment.

Research Opportunities:

  • Investigating Dosage Forms: How can this compound be effectively formulated for maximum efficacy?
  • Synthesizing Derivatives: Can slight modifications lead to compounds with enhanced therapeutic profiles?
  • Exploring Side Effects: What are the implications of long-term usage of this compound in clinical settings?

In conclusion, the study of 7-chloro-5-(2-fluorophenyl)-1-[3-[4-(2-vinyloxyethyl)piperazin-1-yl]propyl]-3H-1,4-benzodiazepin-2-one is not just about understanding its structure, but rather exploring the potential it holds for advancing medical science.